Intrathecal Urokinase Infusion Through a Microcatheter into the Cisterna Magna to Prevent Cerebral Vasospasm: Experimental Study in Dogs

References

1. ↵
   Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9

   PubMedWeb of Science
2. Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 1983;33:424–436

   Abstract/FREE Full Text
3. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys, I: clinical and radiological findings. J Neurosurg 1984;60:1167–1175

   PubMedWeb of Science
4. Seifert V, Eisert WG, Stolke D, Goetz C. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 1989;25:590–598

   CrossRefPubMed
5. ↵
   Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995;9:375–390

   CrossRefPubMedWeb of Science
6. ↵
   Mizoi K, Yoshimoto T, Fujiwara S, Sugawara T, Takahashi A, Koshu K. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report. Neurosurgery 1991;28:807–813

   PubMed
7. Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991;75:181–188

   PubMed
8. ↵
   Ohman J, Servo A, Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991;75:197–201

   PubMed
9. ↵
   Kinugasa K, Kamata I, Hirotsune N, et al. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. J Neurosurg 1995;83:34–41

   PubMed
10. ↵
    Hamada J, Mizuno T, Kai Y, Morioka M, Ushio Y. Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 2000;31:2141–2148

    Abstract/FREE Full Text
11. ↵
    Mizuno T, Hamada J, Kai Y, Todaka T, Morioka M, Ushio Y. Single blood injection into the ventral cisterna magna through a microcatheter for the production of delayed cerebral vasospasm: experimental study in dogs. AJNR Am J Neuroradiol 2003;24:608–612

    Abstract/FREE Full Text
12. ↵
    Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM. Antisense preproendothelin-oligo DNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 1999;90:1105–1114

    CrossRefPubMed
13. ↵
    Morita T, Kato H, Iwanaga S, Takada K, Kimura T. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem (Tokyo) 1977;82:1495–1498

    Abstract/FREE Full Text
14. ↵
    Findlay JM, Weir BKA, Kanamaru K, Grace M, Baughman R. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 1990;26:201–206

    CrossRefPubMedWeb of Science
15. ↵
    Yoshida Y, Ueki S, Takahashi A, Takagi H, Torigoe H, Kudo S. Intrathecal irrigation with urokinase in ruptured cerebral aneurysm cases: basic study and clinical application. Neurol Med Chir (Tokyo) 1985;25:989–997
16. ↵
    Ikeda K, Asakura H, Futami K, Yamashita J. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 1997;41:344–349; discussion 349–350

    CrossRefPubMed
17. ↵
    Zabramski JM, Spetzler RF, Lee KS, et al. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991;75:189–1961

    CrossRefPubMed